Yu Dechao (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Yu Dechao" in English language version.

refsWebsite

Global rank English rank

3books.google.com

3^rd place

3doi.org

2^nd place

3nih.gov

4^th place

2semanticscholar.org

11^th place

8^th place

1bloomberg.com

99^th place

77^th place

1cas.cn

7,476^th place

9,001^st place

1chinadaily.com.cn

831^st place

730^th place

1thestar.com.my

574^th place

425^th place

1seu.edu.cn

low place

1zafu.edu.cn

low place

1etnet.com.hk

low place

1people.com.cn

351^st place

1,081^st place

1asianscientist.com

low place

1thelancet.com

2,393^rd place

3,174^th place

1nmpa.gov.cn

low place

asianscientist.com (Global: low place; English: low place)

"China Approves Tyvyt For Hodgkin's Lymphoma". Asian Scientist Magazine. Apr 20, 2017. Retrieved January 9, 2019.

bloomberg.com (Global: 99^th place; English: 77^th place)

"Capital Group Eyes Pre-IPO Stake in China Biotech Unicorn". Bloomberg News. Retrieved 15 January 2018.

books.google.com (Global: 3^rd place; English: 3^rd place)

Macular Degeneration: New Insights for the Healthcare Professional: 2013 Edition: ScholarlyBrief. ScholarlyEditions. 22 July 2013. pp. 22–. ISBN 978-1-4816-5391-6.
Pablo Hernáiz Driever; Samuel D. Rabkin (1 January 2001). Replication-competent Viruses for Cancer Therapy. Karger Medical and Scientific Publishers. pp. 56–. ISBN 978-3-8055-7248-4.
Shuren Zhang (30 May 2016). Progress in Cancer Immunotherapy. Springer. pp. 244–. ISBN 978-94-017-7555-7.

cas.cn (Global: 7,476^th place; English: 9,001^st place)

alumni.cas.cn

"Michael Yu:High Quality Drugs Should be Affordable to Ordinary People". Chinese Academy of Sciences. Retrieved 1 December 2015.

chinadaily.com.cn (Global: 831^st place; English: 730^th place)

"Recruitment program a magnet for talent". China Daily. Apr 20, 2017.

doi.org (Global: 2^nd place; English: 2^nd place)

Liang, M. (2018). "Oncorine, the World First Oncolytic Virus Medicine and its Update in China". Current Cancer Drug Targets. 18 (2): 171–176. doi:10.2174/1568009618666171129221503. PMID 29189159.
Ansell, S. M. (2019). "Sintilimab: Another effective immune checkpoint inhibitor in classical Hodgkin lymphoma". The Lancet. Haematology. 6 (1): e2–e3. doi:10.1016/S2352-3026(18)30210-2. PMID 30612711. S2CID 58561198.
Hoy, S. M. (2019). "Sintilimab: First Global Approval". Drugs. 79 (3): 341–346. doi:10.1007/s40265-019-1066-z. PMID 30742278. S2CID 59945274.

etnet.com.hk (Global: low place; English: low place)

corpsv.etnet.com.hk

"directors and senior management" (PDF). etnet.com. Retrieved 18 October 2018.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Liang, M. (2018). "Oncorine, the World First Oncolytic Virus Medicine and its Update in China". Current Cancer Drug Targets. 18 (2): 171–176. doi:10.2174/1568009618666171129221503. PMID 29189159.
Ansell, S. M. (2019). "Sintilimab: Another effective immune checkpoint inhibitor in classical Hodgkin lymphoma". The Lancet. Haematology. 6 (1): e2–e3. doi:10.1016/S2352-3026(18)30210-2. PMID 30612711. S2CID 58561198.
Hoy, S. M. (2019). "Sintilimab: First Global Approval". Drugs. 79 (3): 341–346. doi:10.1007/s40265-019-1066-z. PMID 30742278. S2CID 59945274.

nmpa.gov.cn (Global: low place; English: low place)

"治疗霍奇金淋巴瘤的PD-1抗体药物信迪利单抗注射液获批上市". nmpa.gov.cn. Retrieved 28 December 2018.

people.com.cn (Global: 351^st place; English: 1,081^st place)

paper.people.com.cn

"加快迈向新药研发大国". People's Daily. Retrieved Feb 20, 2019.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Ansell, S. M. (2019). "Sintilimab: Another effective immune checkpoint inhibitor in classical Hodgkin lymphoma". The Lancet. Haematology. 6 (1): e2–e3. doi:10.1016/S2352-3026(18)30210-2. PMID 30612711. S2CID 58561198.
Hoy, S. M. (2019). "Sintilimab: First Global Approval". Drugs. 79 (3): 341–346. doi:10.1007/s40265-019-1066-z. PMID 30742278. S2CID 59945274.

seu.edu.cn (Global: low place; English: low place)

seugs.seu.edu.cn

"关于公布江苏省第五批产业教授（兼职）" (PDF). Southeast University. Retrieved Dec 28, 2017.

thelancet.com (Global: 2,393^rd place; English: 3,174^th place)

Ansell, S. M. (2019). "Sintilimab: Another effective immune checkpoint inhibitor in classical Hodgkin lymphoma". The Lancet. Haematology. 6 (1): e2–e3. doi:10.1016/S2352-3026(18)30210-2. PMID 30612711. S2CID 58561198.

thestar.com.my (Global: 574^th place; English: 425^th place)

"Capital Group eyeing stake in China biotech unicorn". The Star (Malaysia). Retrieved 17 January 2018.

zafu.edu.cn (Global: low place; English: low place)

jxxy.zafu.edu.cn

"集贤大讲坛：开发出中国老百姓用得起的高质量生物药". Zhejiang A & F University. Retrieved Apr 13, 2017.

Yu Dechao (English Wikipedia)

asianscientist.com (Global: low place; English: low place)

bloomberg.com (Global: 99th place; English: 77th place)

books.google.com (Global: 3rd place; English: 3rd place)

cas.cn (Global: 7,476th place; English: 9,001st place)

alumni.cas.cn

chinadaily.com.cn (Global: 831st place; English: 730th place)

doi.org (Global: 2nd place; English: 2nd place)

etnet.com.hk (Global: low place; English: low place)

corpsv.etnet.com.hk

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

nmpa.gov.cn (Global: low place; English: low place)

people.com.cn (Global: 351st place; English: 1,081st place)

paper.people.com.cn

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

seu.edu.cn (Global: low place; English: low place)

seugs.seu.edu.cn

thelancet.com (Global: 2,393rd place; English: 3,174th place)

thestar.com.my (Global: 574th place; English: 425th place)

zafu.edu.cn (Global: low place; English: low place)

jxxy.zafu.edu.cn

bloomberg.com (Global: 99^th place; English: 77^th place)

books.google.com (Global: 3^rd place; English: 3^rd place)

cas.cn (Global: 7,476^th place; English: 9,001^st place)

chinadaily.com.cn (Global: 831^st place; English: 730^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

nih.gov (Global: 4^th place; English: 4^th place)

people.com.cn (Global: 351^st place; English: 1,081^st place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

thelancet.com (Global: 2,393^rd place; English: 3,174^th place)

thestar.com.my (Global: 574^th place; English: 425^th place)